Conference Material
|Slide Presentation

24-week regimens for treatment of rifampicin-resistant tuberculosis: four-arm randomised trial

Berry C, Motta I, Kazounis E, Fielding K, Dodd M, Nyang'wa BT, Moodliar R
Download

No abstract available

Countries

Belarus South Africa Uzbekistan

Subject Area

antibiotic resistancetuberculosisantimicrobial resistance

Languages

English
DOI
10.57740/v9ye-0032
Published Date
11 May 2022
Conference
MSF Scientific Days International 2022
Linked Content
Conference Material
|Abstract
24-week regimens for treatment of rifampicin-resistant tuberculosis: four-arm randomised trial
2022 May 11 • MSF Scientific Days International 2022
Conference Material
|Video
24-week regimens for treatment of rifampicin-resistant tuberculosis: four-arm randomised trial
2022 June 07 • MSF Scientific Days International 2022
Similar Content
Abstract
|Abstract
24-week regimens for treatment of rifampicin-resistant tuberculosis: four-arm randomised trial
2022 May 11 • MSF Scientific Days International 2022
Video
|Video
24-week regimens for treatment of rifampicin-resistant tuberculosis: four-arm randomised trial
2022 June 07 • MSF Scientific Days International 2022
Loading...
logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5127.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5127.produseast1